Literature DB >> 16043340

Structure of rhodopsin and the metarhodopsin I photointermediate.

Gebhard F X Schertler1.   

Abstract

The structure of the visual pigment rhodopsin in the dark state was first investigated by electron microscopy (EM). More recently, rhodopsin has been crystallised in two different space groups--a tetragonal P4(1) crystal form and a trigonal P3(1) packing arrangement. The structures of the pigment, determined by X-ray crystallography from these two crystal forms, show many similarities, but also significant differences. These differences are most extensive in the G-protein-binding region of the cytoplasmic surface, where the location of the loop between helices 5 and 6 is highly variable. A combination of EM and spin labelling suggests that this loop adopts the native conformation in the P3(1) crystal form. The X-ray structures also show the location of structural water molecules that are important for colour tuning, stabilisation of the ground state and receptor activation, and act as a template for modelling other G-protein-coupled receptors. A major current focus of structural work on rhodopsin is investigation of the activated state of the receptor. After careful spectroscopic characterisation of light activation in two-dimensional crystals, a map of the metarhodopsin I intermediate was obtained by EM from two-dimensional crystals. In addition, NMR studies are providing information about the structure of activated states of rhodopsin. In the future, structural information will show how rhodopsin becomes activated and how it couples to downstream signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043340     DOI: 10.1016/j.sbi.2005.07.010

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  31 in total

1.  Arrestin-rhodopsin binding stoichiometry in isolated rod outer segment membranes depends on the percentage of activated receptors.

Authors:  Martha E Sommer; Klaus Peter Hofmann; Martin Heck
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

Review 2.  Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers.

Authors:  Patricia H Reggio
Journal:  AAPS J       Date:  2006-05-12       Impact factor: 4.009

3.  Conformational states and dynamics of rhodopsin in micelles and bilayers.

Authors:  Ana Karin Kusnetzow; Christian Altenbach; Wayne L Hubbell
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

Review 4.  G protein coupled receptor structure and activation.

Authors:  Brian K Kobilka
Journal:  Biochim Biophys Acta       Date:  2006-11-15

5.  Arrestin can act as a regulator of rhodopsin photochemistry.

Authors:  Martha E Sommer; David L Farrens
Journal:  Vision Res       Date:  2006-10-27       Impact factor: 1.886

Review 6.  Conformational changes in G-protein-coupled receptors-the quest for functionally selective conformations is open.

Authors:  C Hoffmann; A Zürn; M Bünemann; M J Lohse
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

7.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

8.  Structural and dynamic effects of cholesterol at preferred sites of interaction with rhodopsin identified from microsecond length molecular dynamics simulations.

Authors:  George Khelashvili; Alan Grossfield; Scott E Feller; Michael C Pitman; Harel Weinstein
Journal:  Proteins       Date:  2009-08-01

9.  Structural biology: A moving story of receptors.

Authors:  Thue W Schwartz; Wayne L Hubbell
Journal:  Nature       Date:  2008-09-25       Impact factor: 49.962

10.  Two protonation switches control rhodopsin activation in membranes.

Authors:  Mohana Mahalingam; Karina Martínez-Mayorga; Michael F Brown; Reiner Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.